Medical and Pharmaceutical 60 Degrees Pharma signs patent agreement with Yale for tick disease medicine development The newly announced partnership sent shares up by 137% at the intraday peak on the Nasdaq Tuesday Rowan DunneApril 8, 2025
Psychedelics Algernon partners with Yale University for phase II DMT study Algernon will provide cGMP DMT for the study in exchange for part-ownership of IP generated Rowan DunneOctober 24, 2022
Medical and Pharmaceutical Psilocybin restores brain areas damaged by depression, study shows Psilocybin has a restorative effect on neurons in frontal areas of the brain, according to researchers at Yale University Natalia Buendia CalvilloJuly 19, 2021